The XFG variant of Covid-19, also known as American Covid, is actively spreading across the UK and the government has named ...

Sjogren's disease study, while positive FB102 data in celiac disease offer a contrasting pipeline development.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

New research shows the artificial sweetener sucralose slows autoimmune depigmentation in mice and suppresses human CD8+ T ...

Shares in Argenx were down 18% in European morning trading Thursday, wiping out the stock's gains in the year to date. If sustained until close, this would be the stock's biggest one-day percentage ...

Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY study of efgartigimod subcutaneous ...

Study met primary endpoint of change from baseline in the ratio of Vh:Cd (p=0.0176)First Phase 2 evidence that blocking CD122 can prevent ...

Pediatric immune-mediated inflammatory diseases are genetically distinct from their adult counterparts and should not be viewed as “younger versions of adult diseases,” according to data published in ...

Autoimmune diseases are common, such as rheumatoid arthritis, psoriasis and type 1 diabetes, but despite their prevalence, ...

An Idaho State University biologist and her students are exploring new ways to fight autoimmune diseases afflicting millions.

ZUG, Switzerland, BOSTON - CRISPR Therapeutics (Nasdaq: CRSP), announced that a poster presentation highlighting the Company's Phase 1 clinical data of its investigational CRISPR/Cas9 gene-edited ...

TRex Bio, a Phase 1 biotech developing medicines for autoimmune and inflammatory diseases, announced terms for its IPO on ...